Who owns EVOKE PHARMA INC?
- Ticker: EVOK
- CUSIP Number: 30049g302
Tip: Access positions for across all investors
Analyze quarterly positions in Evoke Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Evoke Pharma stock
Who bought or sold EVOKE PHARMA INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Nantahala Capital Management | 148k | $736k | 0% | Sep 2025 |
|
| Bleichroeder | 146k | $728k | 113% | Sep 2025 |
|
| National Wealth Management Group | 80k | $398k | 100% | Sep 2025 |
|
| DRW Holdings | 24k | $118k | 100% | Sep 2025 |
|
| Vanguard Group | 19k | $93k | 100% | Sep 2025 |
|
| Two Sigma Securities | 10k | $52k | 100% | Sep 2025 |
|
| Advisor Group Holdings | 3.0k | $16k | 100% | Sep 2025 |
|
| Northwestern Mutual Wealth Management Company | 272.00 | $1.4k | 100% | Sep 2025 |
|
| Royal Bank of Canada | 190.00 | $1.0k | 100% | Sep 2025 |
|
| BlackRock | 122.00 | $605.998400 | 0% | Sep 2025 |
|
| SBI Securities | 76.00 | $378.001200 | 1% | Sep 2025 |
|
| Morgan Stanley | 64.00 | $166.003200 | 100% | Jun 2025 |
|
| Tower Research Capital | 40.00 | $199.000000 | -98% | Sep 2025 |
|
| Goss Wealth Management | 17.00 | $84.000400 | 0% | Sep 2025 |
|
Who sold out of Evoke Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 13k | $33k |
| FMR | Jun 2025 | 301.00 | $791.991200 |